Login / Signup
Meifang Li
ORCID
Publication Activity (10 Years)
Years Active: 2021-2021
Publications (10 Years): 1
Top Topics
Double Blind
Clinical Trial
Tyrosine Kinase
Phase Ii
Top Venues
Journal of inflammation research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Jinghui Lin
,
Meifang Li
,
Shijie Chen
,
Lihong Weng
,
Zhiyong He
Efficacy and Safety of First-Generation EGFR-TKIs Combined with Chemotherapy for Treatment-Naïve Advanced Non-Small-Cell Lung Cancer Patients Harboring Sensitive EGFR Mutations: A Single-Center, Open-Label, Single-Arm, Phase II Clinical Trial.
Journal of inflammation research
14 (2021)